TLYB.F TATE +LYLE LS-2916666667
- Market cap
- EUR 2.99B
- P/E
- 37.5x
- P/B
- 1.60x
- ROE
- 6.1%
- Dividend yield
- 3.41%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is TLYB.F undervalued?
Graham numberTLYB.F trades 63.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
TATE +LYLE LS-2916666667 fundamental analysis
No fundamental analysis for TATE +LYLE LS-2916666667 yet.
TATE +LYLE LS-2916666667 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About TATE +LYLE LS-2916666667
Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company's products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, ho…
Full company profileTATE +LYLE LS-2916666667 financial statements
TATE +LYLE LS-2916666667 annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.38B | 1.75B | 1.65B | 1.74B | 2.01B |
| Gross Profit | 514M | 733M | 708M | 706M | 622M |
| Operating Income | 166M | 228M | 235M | 106M | 244M |
| EBITDA | - | 279M | 320M | 254M | 360M |
| Net Income | 236M | 190M | 188M | 143M | 97.0M |
| EPS | 0.59 | 0.47 | 0.47 | 0.32 | 0.22 |
| Balance Sheet | |||||
| Total Assets | 3.25B | 2.51B | 2.28B | 3.73B | 3.67B |
| Total Liabilities | 1.63B | 1.32B | 1.04B | 2.14B | 2.07B |
| Shareholders' Equity | 1.62B | 1.19B | 1.24B | 1.59B | 1.60B |
| Cash & Short-term Investments | 110M | 475M | 437M | 334M | 344M |
| Cash Flow | |||||
| Operating Cash Flow | 103M | 66.0M | 208M | 164M | 230M |
| Capital Expenditure | 148M | 78.0M | 110M | 121M | 125M |
| Free Cash Flow | -45.0M | -12.0M | 98.0M | 43.0M | 105M |
| Ratios | |||||
| ROE | 14.6% | 16.0% | 15.2% | 9.0% | 6.1% |
| ROA | 7.3% | 7.6% | 8.2% | 3.8% | 2.6% |
| Net Profit Margin | 17.2% | 10.9% | 11.4% | 8.2% | 4.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
TATE +LYLE LS-2916666667 dividends
- Dividend yield
- 3.41%
- Forward dividend
- 0.23 EUR
- Payout ratio
- 90.7%
- Ex-dividend date
- Nov 19, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | GBP 88.0M | 0.20 | 90.7% |
| 2025 | GBP 80.0M | 0.18 | 55.9% |
| 2024 | GBP 76.0M | 0.19 | 40.4% |
| 2023 | GBP 570M | 1.42 | 300.0% |
| 2022 | GBP 144M | 0.36 | 61.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 6:7 on May 3, 2022.
Who owns TATE +LYLE LS-2916666667
- Insiders 18.66%
- Institutions 64.17%
- Public & others 17.16%
- Shares outstanding 443M
- Free float 355M
TATE +LYLE LS-2916666667 company profile
- Company name
- TATE +LYLE LS-2916666667
- Ticker
- TLYB.F
- ISIN
- GB00BP92CJ43
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 4,840
- Fiscal year end
- March
- Address
- 5 Marble Arch, London, United Kingdom, W1H 7EJ
- Phone
- 44 20 7257 2100
- Website
- tateandlyle.com
About TATE +LYLE LS-2916666667
Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverages, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. Its portfolio includes sweeteners, fibres, stabilisers and functional systems, hydrocolloids, and starches, proteins, and functional flours. The company's products are used in beverages, dairy, soups, sauces and dressings, bakery and snacks, confectionery, household, clinical nutrition, industrial, meat and seafood, and personal care applications. The company has a strategic collaboration with BioHarvest Sciences Inc. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
TATE +LYLE LS-2916666667 management
10- Mr. Anthony Nicholas Seymour Hampton M.A., MA (Hons)CEO & Executive Director · born 1967
- Ms. Sarah Mary Kuijlaars F.C.M.A., M.A.CFO & Director · born 1967
- Mr. Christopher MarshVice President of Investor Relations
- Ms. Lindsay Claire BeardsellGeneral Counsel · born 1976
- Ms. Lauren HigginsHead of Ethics and Compliance
- Ms. Tamsin VineChief People Officer
- Mr. Rowan AdamsChief Corporate Affairs & Sustainability Officer
- Ms. Melissa LawChief Commercial & Transformation Officer · born 1974
- Ms. Victoria Spadaro GrantChief Science & Innovation Officer
- Jan-Jaap Van Der BijSenior Vice President of Global Environment, Health, Safety, Quality & Security